For patients of reproductive age with a positive ER of tumor, the postoperative application of estrogen receptor modulators (Tamoxifen and Raloxifene), aromatase inhibitor (Letrozole), and GnRH-a would help reduce the recurrence rate. The gene discussed is GNRH1; the disease is neoplasm.